Eli Lilly plans three major diabetes therapy projects in Indianapolis


Eli Lilly and Co. is seeking roughly $24 million in tax abatements over a decade for three major diabetes therapy projects at its technology center, reports the Indianapolis Star.

Plans call for the construction of a new 16,300-sq.-ft. building and the renovation of two existing spaces at the company’s technology campus off of South Harding Street on the west side.

The two renovations involve a $70 million investment to existing space for the development of drug-delivery devices and packaging and a $113 million investment for a syringe-filling assembly line for its diabetes therapy products, according to the Star.

Construction would take place later this year, with the anticipated completion in 2022.


Please enter your comment!
Please enter your name here

one × five =

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.